Immediate Effects of Automatic Lateralization in Critically Ill Patients

NCT07087600 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-11-25

No results posted yet for this study

Summary

New devices have been used in intensive care to optimize respiratory function in critically ill patients, such as automatic lateralization therapy. However, the times and angles used vary widely, and there is no clear evidence of cardiovascular safety and immediate effects, which represents a gap in the literature. This quasi-experimental study aims to evaluate the imediact efficacy and cardiorespiratory safety of automatic lateralization therapy in critically ill patients under invasive mechanical ventilation. The primary outcomes include changes in ventilation distribution and end-expiratory impedance variation. Secondary outcomes include respiratory mechanics, vital signs, and adverse events.

Conditions

  • Intensive Care Units

Interventions

OTHER

Automatic lateralization therapy

Program the bed to vary angle and time continuously during the intervention

OTHER

Supine Positioning

In this intervention, participants will be positioned in the supine position with the head of the bed elevated at 30°

Sponsors & Collaborators

  • Universidade Federal de Pernambuco

    collaborator OTHER
  • Coordination for the Improvement of Higher Education Personnel

    collaborator OTHER
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    collaborator OTHER_GOV
  • Fundação de Amparo à Ciência e Tecnologia de Pernambuco

    collaborator OTHER
  • University of Pernambuco

    lead OTHER

Principal Investigators

  • Shirley Lima Campos, PhD · Universidade Federal de Pernambuco

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-14
Primary Completion
2025-09-30
Completion
2025-10-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07087600 on ClinicalTrials.gov